✦ LIBER ✦

Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study

✍ Scribed by Laura G. Estevez; José Luis Fortes; Encarna Adrover; Gloria Peiró; Mireia Margelí; Eva Castellá; José Miguel Cuevas; Laia Bernet; Miguel Angel Segui; Xavier Andreu; Spanish Breast Cancer Research Group (GEICAM)

Publisher: Springer Milan
Year: 2009
Tongue: Spanish
Weight: 244 KB
Volume: 11
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-009-0311-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A dose-dense schedule of docetaxel follo

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

✍ Silvia Antolín; Ramón Mel; Manuel Ramos; Andrés García-Palomo; Concepción Almanz 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 118 KB

Prospective phase II study of neoadjuvan

Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer

✍ Taher A. Al-Tweigeri; Dahish S. Ajarim; Adher A. Alsayed; Mohamed M. Rahal; Moha 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 272 KB

Biweekly docetaxel and gemcitabine as ne

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study

✍ L. G. Estévez; P. Sánchez-Rovira; M. Dómine; A. León; I. Calvo; A. Jaén; V. Casa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 80 KB

Phase 2 study of neoadjuvant treatment w

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

✍ A. J. Montero; C. M. Diaz-Montero; Y. E. Deutsch; J. Hurley; L. G. Koniaris; T. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 398 KB

A phase II randomized study comparing na

A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer

✍ M. Ghosn; P. Aftimos; F. S. Farhat; J. G. Kattan; C. Hanna; N. Haddad; F. Nasr; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 447 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views